Thus, PRR15 silencing demonstrably compromised Akt-mTOR signaling, resulting in consequent suppression of proliferation, induction of apoptosis, and ultimately, impeded NSCLC xenograft tumor growth. The gene discussed is MTOR; the disease is neoplasm.